Zobrazeno 1 - 10
of 23
pro vyhledávání: '"G B, Schreiber"'
Publikováno v:
Transfusion. 37:996-1002
Concern over the theoretical possibility of disease transmission via blood from donors who develop Creutzfeldt-Jakob disease has led to proposals to exclude older individuals from donating plasma for further manufacture into pooled plasma donations.
Publikováno v:
Canadian Medical Association journal. 113(10)
Publikováno v:
Transfusion. 50(6)
In the United States, African Americans donate at approximately half the rate of whites and therefore are underrepresented in the volunteer blood donor pool. The goal of this study was to identify motivators and barriers to African Americans donating
Autor:
B, Wang, M J, Higgins, S, Kleinman, G B, Schreiber, E L, Murphy, S A, Glynn, D J, Wright, C C, Nass, D, Chang, M P, Busch
Publikováno v:
Transfusion. 44(8)
Increasing concern about transfusion transmission of variant Creutzfeldt-Jakob disease has resulted in indefinite deferral of transfused donors in France and the UK. Little is known, however, about the impact of indefinite deferral of transfused dono
Autor:
S E, Rugege-Hakiza, S A, Glynn, S T, Hutching, J, Bethel, C C, Nass, R L, McEntire, N V, Hirschler, J G, Campbell, A, Ladavac, G B, Schreiber
Publikováno v:
Transfusion. 43(8)
Blood donors with high-risk behaviors may not self-defer because they failed to read or understand the screening educational materials.In 1993, a total of 34,726 allogeneic donors responded to an anonymous mail survey of 50,162 donors that inquired a
Publikováno v:
Transfusion. 40(8)
To evaluate whether the active recruitment of young donors of high school and college age could affect the safety of the blood supply, prevalence and incidence rates of infectious disease markers among donors aged 17 to 18 and 19 to 22 were compared
Publikováno v:
Archives of pathologylaboratory medicine. 124(4)
The human T-lymphotropic viruses types 1 and 2 (HTLV-1 and HTLV-2) are highly prevalent among injection drug users in the United States. However, the clinical course of infection has not been well characterized.To understand HTLV-1-and HTLV-2-associa
Publikováno v:
Vox sanguinis. 78(1)
Although immunoglobulin (Ig) preparations including RhIg have been noted for their record of safety, recent reports of hepatitis C virus (HCV) transmission by some Ig preparations have raised concern. This analysis examined the safety of RhIg manufac
Autor:
E L, Murphy, S M, Bryzman, S A, Glynn, D I, Ameti, R A, Thomson, A E, Williams, C C, Nass, H E, Ownby, G B, Schreiber, F, Kong, K R, Neal, G J, Nemo
Publikováno v:
Hepatology (Baltimore, Md.). 31(3)
Injection drug use (IDU) is a known risk factor for hepatitis C virus (HCV) infection, but the strength of other parenteral and sexual risk factors is unclear. In 1997, we performed a case-control study of 2,316 HCV-seropositive blood donors and 2,31
Publikováno v:
The International journal of eating disorders. 27(1)
This study sought to provide reference data for the Eating Disorder Inventory (EDI) with use of young adolescent black and white girls. Moreover, the study examined the relationship between race, age, socioeconomic status, and adiposity and each of t